Genomics of chronic obstructive pulmonary disease (COPD); exploring the SNPs of protease-antiprotease pathway

Current Genomics

Volumn 14, Issue 3, 2013, Pages 204-213

  Kumar, Manish ^a   Phougat, Neetu ^a   Ruhil, Sonam ^a   Dhankhar, Sandeep ^a   Balhara, Meenakshi ^a   Chhillar, Anil Kumar ^a  

^a MAHARSHI DAYANAND UNIVERSITY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE B; MATRIX METALLOPROTEINASE; PROTEINASE; PROTEINASE INHIBITOR; SERINE PROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE;

ALLELE; CHRONIC OBSTRUCTIVE LUNG DISEASE; DISEASE ASSOCIATION; EXON; GENE; GENOMICS; HUMAN; INFLAMMATION; LUNG DISEASE; PATHOPHYSIOLOGY; PREVALENCE; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 84878665453     PISSN: 13892029     EISSN: 18755488     Source Type: Journal    
DOI: 10.2174/1389202911314030006     Document Type: Review

References (111)

1. Quanjer PH, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R, Yernault JC, "Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society," Eur. Respir. J, 1993, 6, 5-40.
2. Siafakas NM, Vermeire P, Pride NB, Paoletti P, Gibson J, Howard P, Yernault JC, Decramer M, Higenbottam T, Postma DS, Rees J, "Optimal assessment and management of chronic obstructive pulmonary disease (COPD)," Eur. Respir. J., 1995, 8, 1398-1420.
3. Pauwels RA, Buist AS, Calverley PM, Jenkins CR, Hurd SS, "Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary," Am. J. Respir. Crit. Care Med., 2001, 163, 1256-1276.
4. Burrows B, Earle RH, "Course and prognosis of chronic obstructive lung disease," N. Engl. J. Med., 1969, 280, 397-404.
5. Jeffery PK, "Differences and similarities between chronic obstructive pulmonary disease and asthma," Clin. Exp. Allergy, 1999, 29, 14-26.
6. Beck GJ, Doyle CA, Schachter EN, "Smoking and lung function," Am. Rev. Respir. Dis., 1981, 123, 149-155.
7. Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJL, "Global burden of disease and risk factors," Washington DC: The World Bank. 2006.
8. Abegunde DO, Mathers CD, Adam T, Ortegon M, Strong K. "The burden and costs of chronic diseases in low-income and middleincome countries," Lancet, 2007, 370, 1929-1938.
9. Buist AS, McBurnie MA, Vollmer WM, Gillespie S, Burney P, Mannino DM, Menezes AM, Sullivan SD, Lee TA, Weiss KB, Jensen RL, Marks GB, Gulsvik A, Nizankowska-Mogilnicka E, "BOLD Collaborative Research Group. International variation in the prevalence of COPD (The BOLD Study): a population-based prevalence study," Lancet, 2007, 370, 741-750.
10. Mehrotra A, Oluwole AM, Gordon SB, "The burden of COPD in Africa: a literature review and prospective survey of the availability of spirometry for COPD diagnosis in Africa," Tropical Medicine and International Health, 2009, 14(8), 840-848.
11. MeiLan KH, Postma D, Mannino DM, Giardino ND, Buist S, Curtis JL, Martinez FJ, "Gender and Chronic Obstructive Pulmonary Disease. Why It Matters," Am J Respir Crit Care Med, 2007, 176, 1179-1184.
12. Stang P, Lydick E, Silberman C, Kempel A, Keating ET, "The Prevalence of COPD: Using Smoking Rates to Estimate Disease Frequency in the General Population," Chest, 2000, 117, 354S-359S.
13. Murthy K, Sastry J, "Economic burden of chronic obstructive pulmonary disease," In Background papers: The Burden of Disease.: Ministry of Health and Family Welfare, National Commission on Macroeconomics and Health New Delhi, 2005, 265-274.
14. Salvi SS, Barnes PJ, "Chronic obstructive pulmonary disease in non-smokers," Lancet, 2009, 29; 374(9691), 733-43.
15. Sin D, Man S, "Why are patients with chronic obstructive pulmonary disease at increased risk for cardiovascular disease? The potential role of systemic inflammationin chronic obstructive pulmonary disease," Circulation, 2003, 107, 1514-1519.
16. Seemungal T, Harper-Owen R, Bhowmik A, Moric I, Sanderson G, Message S, Maccallum P, Meade TW, Jeffries DJ, Johnston SL, Wedzicha JA, "Respiratory viruses, symptoms and inflammatory markers in acute exacerbations and stable chronic obstructive pulmonary disease," Am. J. Respir. Crit. Care Med., 2001, 164, 1618-1623.
17. Saetta M, Di Stefano A, Turato G, Facchini FM, Corbino L, Mapp CE, Maestrelli P, Ciaccia A, Fabbri LM, "CD8+ T lymphocytes in peripheral airways of smokers with chronic obstructive pulmonary disease," Am. J. Respir. Crit. Care Med., 1998, 157, 822-826.
18. O'Shaughnessy TC, Ansari TW, Barnes NC, Jeffery PK, "Inflammation in bronchial biopsies of subjects with chronic bronchitis: inverserelationship of CD8+ T lymphocytes with FEV1," Am. J. Respir. Crit. Care Med., 1997, 155, 852-857.
19. Saetta M, Baraldo S, Corbino L, Turato G, Braccioni F, Rea F, Cavallesco G, Tropeano G, Mapp CE, Maestrelli P, Ciaccia A, Fabbri LM, "CD8+ ve cells in the lungs of smokers with chronic obstructive pulmonary disease," Am. J. Respir. Crit. Care Med., 1999, 160, 711-717.
20. Saetta M, Baraldo S, Turato G, Beghe B, Casoni GL, Bellettato CM, Rea F, Zuin R, Fabbri LM, Papi A, "Increased proportion of CD8+ T-lymphocytes in the paratracheal lymph nodes of smokers with mild COPD," Sarcoidosis Vasc. Diffuse Lung Dis., 2003, 20, 28-32.
21. Gupta J, Chattopadhaya D, Bhadoria DP, Qadar Pasha MA, Gupta VK, Kumar M, Dabur R, Yadav V, Sharma GL, "T lymphocyte subset profile and serum alpha-1-antitrypsin in pathogenesis of chronic obstructive pulmonary disease," Clin. Exp. Immunol., 2007, 149(3), 463-469.
22. Walker C, Bode E, Boer L, Hansel TT, Blaser K, Virchow JC, "Allergic and nonallergic asthmatics have distinct patterns of T-cell activation and cytokine production in peripheral blood and bronchoalveolar lavage," Am. Rev. Respir. Dis., 1992, 146, 109-115.
23. Leckie MJ, Jenkins GR, Khan J, "Sputum T lymphocytes in asthma,COPDand healthy subjects have the phenotype of activated intraepithelial T cells (CD69+ CD103+)," Thorax, 2003, 58, 23-29.
24. Jeffery PK, "Structural and inflammatory changes in COPD: a comparison with asthma," Thorax, 1998, 53, 129-136.
25. Cosio MG, Guerassimov A, "Chronic obstructive pulmonary disease. Inflammation of small airways and lung parenchyma," Am. J. Respir. Crit. Care Med., 1999, 160, S21-S25.
26. Stefano DA, Capelli A, Lusuardi M, "Decreased T lymphocyte infiltration in bronchial biopsies of subjects with severe chronic obstructive pulmonary disease," Clin. Exp. Allergy, 2001, 31, 893-902.
27. Saetta M, Stefano DA, Maestrelli P, Turato G, Ruggieri MP, Roggeri A, Calcagni P, Mapp CE, Ciaccia A, Fabbri LM, "Airway eosinophilia in chronic bronchitis during exacerbations," Am. J. Respir. Crit. Care Med., 1994, 150, 1646-1652.
28. Qiu Y, Zhu J, Bandi V, Atmar RL, Hattotuwa K, Guntupalli KK, Jeffery PK, "Biopsy neutrophilia, neutrophil chemokine and receptor gene expression in severe exacerbations of chronic obstructive pulmonary disease," Am. J. Respir. Crit. Care Med., 2003, 168, 968-975.
29. Gross P, Pfitzer E, Tolker E, Babyak M, Kaschak M, "Experimental emphysema: its production with papain in normal and silicotic rats," Arch. Environ. Health, 1965, 11, 50-58.
30. Laurell CB, Erikkson S, "The electrophoretic alpha-globulin pattern of serum in alpha-antitrypsin deficiency," Scand. J. Clin. Invest., 1963, 15, 132-140.
31. Belaaouaj A, McCarthy R, Baumann M, Gao Z, Ley TJ, Abraham SN, Shapiro SD, "Mice lacking neutrophil elastase reveal impaired host defense against gram negative bacterial sepsis," Nat. Med., 1998, 4, 615-618.
32. Visse R, Nagase H, Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry," Circ. Res., 2003, 92, 827-839.
33. Betsuyaku T, Nishimura M, Takeyabu K, Tanino M, Venge P, Xu S, Kawakami Y, "Neutrophil granule proteins in bronchoalveolar lavage fluid from subjects with subclinical emphysema, Am. J. Respir. Crit. Care Med., 1999, 159, 1985-1991.
34. Finlay GA, O'Driscoll LR, Russell KJ, D'Arcy EM, Masterson JB, FitzGerald MX, O'Connor CM, "Matrix metalloproteinase expression and production by alveolar macrophages in emphysema" Am. J. Respir. Crit. Care Med., 1997, 156, 240-247.
35. Gross J, Lapiere C, "Collagenolytic activity in amphibian tissues: a tissue culture assay," Proc. Natl. Acad. Sci. U. S. A., 54, 1197-1204.
36. Sternlicht MD, Werb Z, "How matrix metalloproteinases regulate cell behavior," Ann. Rev. Cell. Dev. Biol., 2001, 17, 463-516.
37. Chaudhuri R, McSharry C, Brady J, Donnelly I, Grierson C, McGuinness S, Jolly L, Weir CJ, Messow CM, Spears M, Miele G, Nocka K, Crowther D, Thompson J, Brannigan M, Lafferty J, Sproule M, Macnee W, Connell M, Murchison JT, Shepherd MC, Feuerstein G, Miller DK, Thomson NC, "Sputum matrix metalloproteinase- 12 in patients with chronic obstructive pulmonary disease and asthma: relationship to disease severity," J Allergy Clin Immunol., 2012, 129(3), 655-663.
38. Haq I, Lowrey GE, Kalsheker N, Johnson SR, "Matrix metalloproteinase- 12 (MMP-12) SNP affects MMP activity, lung macrophage infiltration and protects against emphysema in COPD," Thorax., 2011, 66(11), 970-6.
39. Weeks BS, Schnaper HW, Handy M, Holloway E, Kleinman HK, "Human T lymphocytes synthesize the 92 kDa type IV collagenase (gelatinase B)," J. Cell Physiol., 1993, 157, 644-649.
40. Welgus HG, Campbell EJ, Cury JD, Eisen AZ, Senior RM, Wilhelm SM, Goldberg GI, "Neutral metalloproteinases produced by human mononuclear phagocytes. Enzyme profile, regulation, and expression during cellular development," J. Clin. Inves., 1990, 86, 1496-1502.
41. Bernhard EJ, Muschel RJ, Hughes EN, "Mr 92,000 gelatinase release correlates with the metastatic phenotype in transformed rat embryo cells, Cancer Res., 1990, 50, 3872-3877.
42. Murphy G, Nguyen Q, Cockett MI, "Assessment of the role of the fibronectin-like domain of gelatinase A by analysis of a deletion mutant," J. Biol. Chem., 1994, 269, 6632-6636.
43. Wilhelm SM, Collier IE, Marmer BL, Eisen AZ, Grant GA, Goldberg GI, "SV40-transformed human lung fibroblasts secrete a 92- kDa type IV collagenase which is identical to that secreted by normal human macrophages," J. Biol. Chem., 1989, 264, 17213-17221.
44. Zhang B, Ye S, Herrmann SM, Eriksson P, de Maat M, Evans A, Arveiler D, Luc G, Cambien F, Hamsten A, Watkins H, Henney AM, "Functional polymorphism in the regulatory region of gelatinase B gene in relation to severity of coronary atherosclerosis," Circulation, 1999, 99, 1788-1794.
45. Ahrens D, Koch AE, Pope RM, Stein-Picarella M, Niedbala MJ, Expression of matrix metalloproteinase 9 (96-kd gelatinase B) in human rheumatoid arthritis" Arthritis Rheum., 1996, 39, 1576-1587.
46. Konttinen YT, Halinen S, Hanemaaijer R, Sorsa T, Hietanen J, Ceponis A, Xu JW, Manthorpe R, Whittington J, Larsson A, "Matrix metalloproteinase (MMP)-9 type IV collagenase/gelatinase implicated in the pathogenesis of Sjogren's syndrome" Matrix Biol., 1998, 17, 335-347.
47. Faber-Elmann A, Sthoeger Z, Tcherniack A, Dayan M, Mozes E, "Activity of matrix metalloproteinase-9 is elevated in sera of patients with systemic lupus erythematosus," Clin. Exp. Immunol., 2002, 127, 393-398.
48. Lemjabbar H, Gosset P, Lamblin C, "Contribution of 92 KD gelatinase/ type IV collagenase in bronchial inflammation during status asthmaticus," Am. J. Respir. Crit. Care Med., 1999, 159, 1298-1307.
49. Van den Steen PE, Dubois B, Nelissen I, Rudd PM, Dwek RA, Opdenakker G, "Biochemistry and molecular biology of gelatinase B or matrix metalloproteinase-9 (MMP-9)," Crit. Rev. Biochem. Mol. Biol., 2002, 37, 375-536.
50. Okada Y, Gonoji Y, Naka K, "Matrix metalloproteinase 9 (92-kd gelatinase/type IV collagenase) from HT 1080 human fibrosarcoma cells: purification and activation of the precursor and enzymic properties," J. Biol. Chem., 1992, 25, 21712-21719.
51. Louhelainen N, Stark H, Mazur W, Rytila P, Djukanovic R, Kinnula VL, "Elevation of sputum matrix metalloproteinase-9 persists up to 6 months after smoking cessation: a research study," BMC Pulm Med., 10, 13. 2010.
52. Girolamo N, Tedla N, Lloyd A, "Expression of matrix metalloproteinases by human plasma cells and B lymphocytes," Eur. J. Immunol., 1998, 28, 1773-1784.
53. Gosselink JV, Hayashi S, Elliott WM, Xing L, Chan B, Yang L, Wright C, Sin D, Paré PD, Pierce JA, Pierce RA, Patterson A, Cooper J, Hogg JC, "Differential expression of tissue repair genes in the pathogenesis of chronic obstructive pulmonary disease," Am. J. Respir. Crit. Care Med., 2010, 181(12), 1329-1335.
54. Russell RE, Culpitt SV, DeMatos C, Donnelly L, Smith M, Wiggins J, Barnes PJ, "Release and Activity of Matrix Metalloproteinase- 9 and Tissue Inhibitor of Metalloproteinase-1 by Alveolar Macrophages from Patients with Chronic Obstructive Pulmonary Disease," Am. J. Respir. Cell. Mol. Biol., 2002, 26, 602-609.
55. Tager I, Tishler PV, Rosner B, Speizer FE, Litt M, "Studies of the familial aggregation of chronic bronchitis and obstructive airways disease," Int. J. Epidemiol., 1978, 7, 55-62.
56. Madison R, Zelman R, Mittman C, "Inherited risk factors for chronic lung disease," Chest, 1980, 77, 255-257.
57. Khoury MJ, Beaty TH, Newill CA, Bryant S, Cohen BH, "Geneticenvironmental interactions in chronic airways obstruction," Int. J. Epidemiol., 1986, 15, 65-72.
58. Devor EJ, Crawford MH, "Family resemblance for normal pulmonary function," Ann. Hum. Biol., 1984, 11, 439-448.
59. Kauffmann F, Tager IB, Munoz A, Speizer FE, "Familial factors related to lung function in children aged 6-10 years. Results from the PAARC epidemiologic study," Am. J. Epidemiol., 1989, 129, 1289-1299.
60. Redline S, Tishler PV, Lewitter FI, Tager IB, Munoz A, Speizer FE, "Assessment of genetic and nongenetic influences on pulmonary function: A twin study," Am. Rev. Respir. Dis., 1987, 135, 217-222.
61. Sandford AJ, Chagani T, Weir TD, Connett JE, Anthonisen NR, Pare PD, "Susceptibility Genes for Rapid Decline of Lung Function in the Lung Health Study," Am. J. Respir. Crit. Care Med., 2001, 163, 469-73.
62. Zamel N, Webster P, Lorimer E, Man S, Woolf C, "Environmental versus genetics in determining bronchial susceptibility to cigarette smoking," Chest, 1981, 80, 57.
63. Redline S, Tishler P, Lewitter FI, Tager IB, Munoz A, Speizer FE, "Assessment of genetic and nongenetic influences on pulmonary function: A twin study," Am. Rev. Respir. Dis., 1987, 135, 217-222.
64. Hankins D, Drage C, Zamel N, Kronenberg R, "Pulmonary function in identical twins raised apart," Am. Rev. Respir. Dis., 1982, 125, 119-121.
65. Hubert HB, Fabsitz RR, Feinleib M, Gwinn C, "Genetic and environmental influences on pulmonary function in adult twins," Am. Rev. Respir. Dis., 1982, 125, 409-415.
66. McClearn GE, Svartengren M, Pedersen NL, Heller DA, Plomin R, "Genetic and environmental influences on pulmonary function in aging Swedish twins," J. Gerontol., 1994, 49, 264-268.
67. Scott MB, Brose RD, McWilliams R, Naughton K, Coleman B, Lai T, Algire M, uzanne Beck S, Hoover FJ, Hamosh A, Fallin MD, West K, Arking DE, Chakravarti A, Cutler DJ, Cutting GR, "Relative Contribution of Genetic and Non-genetic Modifiers to Intestinal Obstruction in Cystic Fibrosis," Gastroenterology, 2006, 131(4), 1030-1039.
68. Rybicki BA, Beaty TH, Cohen BH, "Major genetic mechanisms in pulmonary function," J. Clin. Epidemiol., 1990, 43, 667-675.
69. Astemborski JA, Beaty TH, Cohen BH, "Variance components analysis of forced expiration in families," Am. J. Med. Genet., 1985, 21, 741-753.
70. Givelber RJ, Couropmitree NN, Gottlieb DJ, Evans JC, Levy D, Myers RH, O'Connor GT, "Segregation analysis of pulmonary function among families in the Framingham Study," Am. J. Respir. Crit. Care Med., 1998, 157, 1445-1451.
71. Chen Y, Horne SL, Rennie DC, Dosman JA, "Segregation analysis of two lung function indices in a random sample of young families: the Humboldt Family Study," Genet. Epidemiol., 1996, 13, 35-47.
72. Shen LH, Zhang XM, Su DJ, Yao SP, Yu BQ, Wang HW, Lu FZ, "Association of Vitamin D Binding Protein Variants with Susceptibility to Chronic Obstructive Pulmonary Disease," J. Int. Med. Res., 2010, 38(3), 1093-1098.
73. Bouma G, Crusius JB, Oudkerk Pool M, Kolkman JJ, von Blomberg BM, Kostense PJ, Giphart MJ, Schreuder GM, Meuwissen SG, Pena AS, "Secretion of tumour necrosis factor alph and lymphotoxin alpha in relation to polymorphisms in the TNF genes and HLA-DR alleles. Relevance for inflammatory bowel disease," Scand. J. Immunol., 1996, 43, 456-463.
74. Moffatt MF, Cookson WO, "Tumour necrosis factor haplotypes and asthma" Hum. Mol. Genet., 1997, 6, 551-554.
75. Chagani T, Paré PD, Zhu S, Weir TD, Bai TR, Behbehani NA, Fitzgerald AJ, Sandford AJ, "Prevalence of tumour necrosis factor-α and angiotensin converting enzyme polymorphisms in mild/moderate and fatal/near-fatal asthma," Am. J. Respir. Crit. Care Med., 1999, 160, 278-282.
76. Huang SL, Su CH, Chang SC, "Tumor necrosis factor- α gene polymorphism in chronic bronchitis," Am. J. Respir. Crit. Care Med., 1997, 156, 1436-1439.
77. Sakao S, Tatsumi K, Igari H, Shino Y, Shirasawa H, Kuriyama T, "Association of tumor necrosis factor alpha gene promoter polymorphism with the presence of chronic obstructive pulmonary disease," Am. J. Respir. Crit. Care Med., 2001, 163, 420-422.
78. Higham MA, Pride NB, Alikhan A, Morrell N, "Tumour necrosis factor-alpha gene promoter polymorphism in chronic obstructive pulmonary disease," Eur. Respir. J., 2000, 15, 281-284.
79. Teramoto S, Ishii T, "No association of tumor necrosis factor alpha gene polymorphism and COPD in Caucasian smokers and Japanese smokers" Chest, 2001, 119, 315-316.
80. Giovine DFS, Takhsh E, Blakemore AI, Duff GW, "Single base polymorphism at -511 in the human interleukin-1 beta gene (IL1 beta)," Hum. Mol. Genet., 1992, 1, 450.
81. Tarlow JK, Blakemore AI, Lennard A, Solari R, Hughes HN, Steinkasserer A, Duff GW "Polymorphism in human IL-1 receptor antagonist gene intron 2 is caused by variable numbers of an 86-bp tandem repeat," Hum. Genet., 1993, 91, 403-404.
82. Blakemore AI, Tarlow JK, Cork MJ, Gordon C, Emery P, Duff GW, "Interleukin-1 receptor antagonist gene polymorphism as a disease severity factor in systemic lupus erythematosus," Arthritis Rheumat., 1994, 37, 1380-1385.
83. Clay FE, Cork MJ, Tarlow JK, Blakemore AI, Harrington CI, Lewis F, Duff GW, "Interleukin 1 receptor antagonist gene polymorphism association with lichen sclerosus," Hum. Genet., 1994, 407-410.
84. Cork MJ, Tarlow JK, Clay FE, Crane A, Blakemore AI, Mc- Donagh AJ, Messenger AG, Duff GW, "An allele of the interleukin- 1 receptor antagonist as a genetic severity factor in alopecia areata," J. Invest. Dermatol., 1995, 104, S15-S16.
85. Mansfield JC, Holden H, Tarlow JK, Di Giovine FS, Mc-Dowell TL, Wilson AG, Holdsworth CD, Duff GW, "Novel genetic association between nulcerative colitis and the anti-inflammatory cytokine interleukin-1 receptor antagonist," Gastroenterology, 1994, 106, 637-642.
86. Joos L, He JQ, Shepherdson MB, Connett JE, Anthonisen NR, Pare PD, Sandford AJ, "The role of matrix metalloproteinase polymorphisms in the rate of decline in lung function," Hum. Mol. Genet., 2002, 11, 569-576.
87. Ishii T, Keicho N, Teramoto S, Azuma A, Kudoh S, Fukuchi Y, Ouchi Y, Matsuse T, "Association of Gc-globulin variation with susceptibility to COPD and diffuse panbronchiolitis," Eur. Respir. J., 2001, 18, 753-757.
88. Pierrou S, Broberg P, O'Donnell RA, Pawłowski K, Virtala R, Lindqvist E, Richter A, Wilson SJ, Angco G, Möller S, Bergstrand H, Koopmann W, Wieslander E, Strömstedt PE, Holgate ST, Davies DE, Lund J, Djukanovic R, "Expression of Genes Involved in Oxidative Stress Responses in Airway Epithelial Cells of Smokers with Chronic Obstructive Pulmonary Disease," Am J Respir Crit Care Med, 2007, 175, 577-586.
89. Arif E, Vibhuti A, Alam P, Deepak D, Singh B, Athar M, Pasha MAQ, "Association of CYP2E1 and NAT2 gene polymorphisms with chronic obstructive pulmonary disease," Clinica Chimica Acta, 2007, 382, 37-42.
90. Carrell RW, Jeppsson JO, Laurell CB, Brennan SO, Owen MC, Vaughan L, Boswell DR, "Structure and variation of human alpha 1-antitrypsin," Nature, 1982, 298, 329-334.
91. Seersholm N, Kok-Jensen A, Dirksen A, "Survival of patients with severe alpha-1-antitrypsin deficiency with special reference to nonindex cases," Thorax, 1994, 49, 695-698.
92. Turino GM, Barker AF, Brantly ML, Cohen AB, Connelly RP, Crystal RG, Eden E, Schluchter MD, Stoller JK, "Clinical features of individuals with PI*SZ phenotype of alpha-1-antitrypsin deficiency. Alpha-1-Antitrypsin Deficiency Registry Study Group," Am. J. Respir. Crit. Care Med., 1996, 154, 1718-1725.
93. Alvarez GL, Cabero-Perez MJ, Bustamante RA, Gonzalez LD, Delgado RM, Garcia FM, "PI SZ phenotype in chronic obstructive pulmonary disease," Thorax, 1997, 52, 659-661.
94. Kueppers F, Miller RD, Gordon H, Hepper NG, Offord K, "Familial prevalence of chronic obstructive pulmonary disease in a matched pair study," Am. J. Med., 1977, 63, 336-342.
95. Bartmann K, Fooke-Achterrath M, Koch G, Nagy I, Schutz I, Weis E, Zierski M, "Heterozygosity in the Pi-system as a pathogenetic cofactor in chronic obstructive pulmonary disease (COPD)," Eur. J. Respir. Dis., 1985, 66, 284-296.
96. Janus ED, "Alpha-1-antitrypsin Pi types in COPD patients," Chest, 1988, 94, 446-447.
97. Lieberman J, Winter B, Sastre A, "Alpha-1-antitrypsin Pi-types in 965 COPD patients," Chest, 1986, 89, 370-373.
98. Sandford AJ, Weir TD, Spinelli JJ, Paré PD, "Z and S mutations of the alpha-1-antitrypsin gene and the risk of chronic obstructive pulmonary disease," Am. J. Respir. Cell Mol. Biol., 1999, 20, 287-291.
99. Watkins GL, Hill S, Morgan K, Stockley RA, Fick RB, "Independent mutations in the flanking sequence of the alpha-1-antitrypsin gene are associated with chronic obstructive airways disease," Dis. Markers, 1990, 8, 151-157.
100. Poller W, Meisen C, Olek K, "DNA polymorphisms of the alpha-1- antitrypsin gene region in patients with chronic obstructive pulmonary disease," Eur. J. Clin. Invest., 1990, 20, 1-7.
101. Bentazzo MG, Botnick WC, Shin JW, "Inhaled bronchodilators reduce dyanamic hyperinflation during exercise in patients with chronic obstructive pulmonary disease," Am. J. Resp. Crit. Care Med., 1996, 153, 967-975.
102. Kwok JS, Lawton JW, Yew WW, Chau CH, Lee J, Wong PC, "Protease inhibitor phenotypes and serum alpha-1-antitrypsin levels in patients with COPD: A study from Hong Kong," Respirology, 2004, 9, 265-270.
103. Kumar M, Bhadoria DP, Koushik Dutta, Singh S, Gupta J, Kumar R, Chhillar AK, Yadav V, Singh B, Sharma GL, "Combinatorial effect of TIMP-1 and α1AT gene polymorphisms on development of chronic obstructive pulmonary disease," Clinical Biochemistry, 2011, 44, 1067-1073.
104. Lindmark B, Svenonius E, Eriksson S, "Heterozygous alpha-1- antichymotrypsin and PiZ alpha-1-antitrypsin deficiency. Prevalence and clinical spectrum in asthmatic children," Allergy, 1990, 45, 197-203.
105. Sandford AJ, Chagani T, Weir TD, Paré PD, "Alpha-1- antichymotrypsin mutations in patients with chronic obstructive pulmonary disease," Dis. Markers, 1998, 13, 257-60.
106. Poller W, Faber JP, Klobeck G, Olek K, "Cloning of the human a2- macroglobulin gene and detection of mutations in two functional domains: the bait region and the thiolester site," Hum. Genet., 1992, 88, 313-319.
107. Rutter JL, Mitchell TI, Buttice G, Meyers J, Gusella JF, Ozelius LJ, Brinckerhoff CE, "A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter creates an ETS binding site and augments transcription," Cancer Res., 1998, 58, 5321-5325.
108. Jormsjo S, Ye S, Moritz J, Walter DH, Dimmeler S, Zeiher AM, Henney A, Hamsten A, Eriksson P, "Allele-specific regulation of matrix metalloproteinase-12 gene activity is associated with coronary artery luminal dimensions in diabetic patients with manifest coronary artery disease," Circ. Res., 2000, 86, 998-1003.
109. Shimajiri S, Arima N, Tanimoto A, Murata Y, Hamada T, Wang KY, Sasaguri Y, "Shortened microsatellite d (CA)21 sequence downregulates promoter activity of matrix metalloproteinase 9 gene," FEBS Lett., 1999, 455, 70-74.
110. Joos L, He JQ, Shepherdson MB, Connett JE, Anthonisen NR, Pare PD, Sandford AJ, "The role of matrix metalloproteinase polymorphisms in the rate of decline in lung function Hum. Mol. Genet., 2002, 11, 569-576.
111. Diemen CCV, Postma DS, Siedlinski M, "Genetic variation in TIMP1 but not MMPs predict excess FEV1 decline in two general population-based cohorts," Respiratory Research, doi, 10.1186/ 1465-9921-12-57, 2011.